期刊文献+

类风湿关节炎患者91例死亡原因及预后因素分析 被引量:8

Causes of death and prognostic indicators of rheumatoid arthritis
原文传递
导出
摘要 目的了解类风湿关节炎(RA)患者主要死因构成及预后因素。方法收集我院1990-2011年91例RA死亡患者临床及血清学资料,分析其死因构成及其与病情活动度、用药情况等的关系,采用t检验和χ2检验、Mann.WhithreyU检验进行统计分析,并应用比例风险模型(Cox参数回归)探讨预后因素。结果合并感染、心脑血管疾病和肿瘤为RA患者最主要的三大死因,分别占总死亡人数的57%、13%、12%。RA病情中高度活动者死亡比例高,占总死亡人数64%。RA死亡患者系统受累常见,其中以全身症状最常见,包括发热、乏力、体质量下降,占总死亡人数的75%,其次为肺间质纤维化、胸腔积液。多因素分析结果显示多关节外表现是RA死亡的独立危险因素,改善病情抗风湿药(DMARDs)的应用是RA的预后保护因素。结论合并感染、心脑血管疾病和肿瘤是RA最主要死亡原因。多关节外表现是RA预后的独立危险因素。 Objective To analyze the causes of death and prognostic indicators of rheumatoid arthritis (RA). Methods A retrospective investigation was performed on 91 RA patients who were admitted into our hospital from 1990 to 2011. The clinical features and laboratory data were studied to assess the causes of death and the relationship between causes of death and disease activity and treatment. T test and χ2 test were used for statistical analysis. Prognostic indicators of mortality were studied by Cox proportional hazards models. The prognostic indicators of RA were also analyzed. Results The three most common causes of death in patients with RA were infection (57%), cardiac-cerebral vascular diseases (13%) and cancer (12%). Severe disease activity and presence of extra-articular manifestations were more common among the patients who died. Seventy-five percent patients presented with systemic symptoms including fever, fatigue and weight loss, foUowed by pulmonary fibrosis (32%) and pleura1 effusion (27%). Cox regression analysis revealed that the presence of extra-articular features was independent risk determinant for mortality while DMARDs treatment was the independent protect determinant. Conclusion Infection, cardiac-cerebral vascular diseases and cancer are the main causes of death in RA. The presence of extra-articular features is the independent risk factor of RA.
出处 《中华风湿病学杂志》 CAS CSCD 北大核心 2013年第8期542-545,共4页 Chinese Journal of Rheumatology
关键词 关节炎 类风湿 死亡原因 预后因素 Arthritis, Rheumatoid Cause of death Prognostic indicators
  • 相关文献

参考文献15

  • 1粟占国.类风湿关节炎在我国的低认知度和高致残率不容忽视[J].中华医学杂志,2009,89(27):1873-1875. 被引量:47
  • 2Young A, Koduri G, Batley M, et al. Mortality in rheumatoidarthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. Rheumatology (Oxford), 2006, 46: 350-357. 被引量:1
  • 3徐建华,连莉,帅宗文,王芬,孙桂华.类风湿关节炎22例死亡原因分析及文献复习[J].中华风湿病学杂志,2004,8(6):342-345. 被引量:2
  • 4Doran M, Crowson C, Pond G, et al. Frequency of infection in patients with rheumatoid arthritis compared with controls. Arthri- tis Rheum, 2002, 46: 2287-2293. 被引量:1
  • 5Young C, Adamson TI, Vaughan J, et al. Immunohistological characterization of synovial membrane lymphecytes in rheumatoid arthritis. Arthritis Rheum, 1984, 27: 32-39. 被引量:1
  • 6Sang KG, KoLluri S, Koehnke RK, et al. Rheumatoid arthritis lung disease: determinants of physiologic and radiographic ab- normalities. Arthritis Rheum, 1996, 39: 1711-1719. 被引量:1
  • 7O'DeU J, Gilg J, Palmer W, et al. Pneumococcal vaccine in rheumatoid arthritis. Decreased response while on methotrexate. J Clin Rheumatol, 1996, 2:59-63. 被引量:1
  • 8Goodson N, Marks J, Lunt M, et al. Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s. Ann Rheum Dis, 2005, 64: 1595-1601. 被引量:1
  • 9Morgan $L, Baggott JE, Lee JY, eta]. Folic acid supplementa- tion prevents deficient blood folate levels and hyperhomocys- teinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease pre- vention. J Rheumatol, 1998, 25: 441-446. 被引量:1
  • 10Laszerini PE, Capecchi PL, Bisogno S, et al. Reduction in plas- ma homocysteine level in patients with rheumatoid arthritis given pulsed g]ucocorticoid treatment. Ann Rheum Dis, 2003, 62: 694-695. 被引量:1

二级参考文献42

  • 1许立德,陈韧,许敬才.类风湿关节炎11例的死亡原因分析[J].中华内科杂志,1996,35(7):485-486. 被引量:2
  • 2马骥良,白泽敏.12例类风湿关节炎患者肾脏活检的组织病理改变[J].中华内科杂志,1996,35(5):336-337. 被引量:10
  • 3栗占国.风湿性疾病的规范化治疗势在必行[J].北京大学学报(医学版),2006,38(4):341-344. 被引量:6
  • 4Grigor C,Capeli H,Stiding A,et al.Effect of a treatment strategy of fight control for rheumatoid arthritis (The TICORA study):a single-blind randomized controlled trial.Lancet,2004,364:263-269. 被引量:1
  • 5Saag KG,Teng GG,Patkar NM,et al.American College of Rheumatology.American College of Rheumatology 2008 recommendations for the use of nonbiologie and biologic diseasemodifying antirheumatie drugs in rheumatoid arthritis.Arthritis Rheum,2008,59:726-784. 被引量:1
  • 6Rantalaiho V,Korpela M,Hannonen P,et al.FIN-RACo Trial Group.The good initial response to therapy with a combination of traditional disease-modifying antirheumatie drugs is sustained over time:the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial.Arthritis Rheum,2009,60:1222-1231. 被引量:1
  • 7Choy EH,Smith C,DoréCJ,et al.A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal.Rheumatology,2005,44:1414-1421. 被引量:1
  • 8Visser K,Katehamart W,Loza E,et al.Multinational evidencebased recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis:integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiation.Ann Rheum Dis,2009,58:1086-1093. 被引量:1
  • 9Niederstadt C, Happ T, Tatasis E, et al. Glomerular and tubular proteinuria as markers of nephropathy in rheumatoid arthritis. Rheumatology (Oxford), 1999, 38: 28-33. 被引量:1
  • 10Koseki Y, Terai C, Moriguhi M, et al. A prospective study of renal disease in patients with early rheumatoid arthritis. Ann Rheum Dis, 2001, 60: 327-331. 被引量:1

共引文献54

同被引文献74

引证文献8

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部